Sermorelin tablets vs injections
Sermorelin tablets vs injections: are the forms equivalent?
Sermorelin tablets and injections should not be treated as equivalent products. The historical Geref record and the small human studies cited by Longevity Ranked concern injectable administration. Current online tablets or dissolvable formulations are compounded products with their own ingredients, route and pharmacy documentation. The cited source set does not include a human head-to-head trial establishing equivalent absorption, dose or outcomes between an online tablet and the injection plans audited here.
Separates injection evidence from tablet claims, then pairs an actual sublingual offer with its advertised bill and unresolved prescription details. It is a bounded source review, not a systematic review or individual medical advice.
Historical record
Geref was an injectable sermorelin product
Current comparison
Sourced injection plans and a separately checked sublingual tablet offer
Head-to-head evidence
No tablet-versus-injection human trial in this bounded review
Are sermorelin tablets the same as injections?
No. Route, formulation, inactive ingredients, absorption and the dispensing product differ. A shared active-ingredient name does not establish dose or outcome equivalence.
The current Longevity Ranked price table covers sourced injection plans only. An oral or dissolvable listing needs its own product record rather than being inserted as a cheaper version of an injection.
Which form has stronger human evidence?
The human mechanism and older-men sources cited on this site concern injected GHRH or sermorelin-related administration. They do not validate an online tablet formulation.
The cited source set does not include a direct human comparison between a current compounded sermorelin tablet and the injection plans in our market audit. That absence should remain explicit instead of being replaced with absorption claims from a seller.
Are sermorelin tablets FDA-approved?
Historical Geref approvals do not transfer to a current compounded tablet or injection. FDA determined that discontinued Geref products had not been withdrawn for safety or effectiveness reasons, but their approvals were withdrawn.
Compounded drugs are not FDA-approved. The exact pharmacy, formulation and prescription label therefore matter for either route.
Does BMI MD sell sermorelin tablets, and what do they cost?
BMI MD's product page describes sublingual tablets, which dissolve under the tongue. Its one-month selection advertises $129 total. The three-month selection shows $109 per month and a $327 term total. These are September 30 advertised offers, not completed checkout quotes or prices for an equivalent injection dose.
Ask for the ingredient strength, tablet count, dispensing pharmacy, required fees and next renewal before paying. The tablet page's injection citations and testimonials do not establish tablet absorption or clinical results. BMI MD's refund policy also distinguishes a clinician decline from cancellation after intake or pharmacy processing.
- BMI MD: sermorelin sublingual tablets and advertised plans
- BMI MD: authorization, refunds and cancellation policy
BMI MD's partner offer excludes California and South Carolina. Check your location before continuing, or visit the provider directly. We may earn a commission from a qualifying partner referral. A link is not a recommendation of treatment or proof of a clinical benefit.
What should I verify before comparing price?
Confirm whether the product is swallowed, dissolved in the mouth or used another way; the active and inactive ingredients; supplied quantity; dispensing pharmacy; full first bill; renewal; and cancellation terms.
Do not divide prices into a cost per equivalent dose unless the products and prescribed quantities are actually comparable. This page does not recommend a route or dose.
Approved partner · source-audited provider
PeterMD
PeterMD sermorelin: four and twelve-week terms.
PeterMD lists $211.65 for four weeks and $585 for twelve weeks. These are term totals; the public page does not establish the future renewal schedule.
Partner link; we may earn a commission. Editorial order and findings do not change.
Partner links track referrals through Katalys/Revoffers. Broad placements use the longevity catalog; product buttons use the exact approved destination. This relationship does not change comparison order or review findings. Refund and auto-bill policy. Checked September 22, 2026.
Where can I compare current sermorelin providers?
The pages below compare public product and contract information. Some are labeled partner links. Any commission we receive does not change evidence claims or table order.
Partner link; we may earn a commission. Editorial order and findings do not change.
Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate.
Which sources support this answer?
Sources were checked September 21, 2026 for the evidence review; BMI MD tablet offer checked September 30, 2026. They define the product, population and evidence limits used above; they do not determine individual suitability.
- FDA: discontinued Geref sermorelin determination
- FDA: understanding the risks of compounded drugs
- PubMed: GHRH(1-29) dose-response study in ten adult men
- PubMed: six-week GHRH study in eleven older men
- BMI MD: sermorelin sublingual tablets and advertised plans
- BMI MD: authorization, refunds and cancellation policy
These are products marketed in the longevity category, not established lifespan-extension treatments. Compounded drugs are not FDA-approved. This publication compares public information; a clinician must assess individual suitability. How we compare.